NF-kappaB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction

AUTOR(ES)

Makarov, Sergei S

FONTE

BioMed Central

RESUMO

The transcription factor NF-κB has been well recognized as a pivotal regulator of inflammation in rheumatoid arthritis (RA), but recent developments revealed a broad involvement of NF-κB in other aspects of RA pathology, including development of T helper 1 responses, activation, abnormal apoptosis and proliferation of RA fibroblast-like synovial cells, and differentiation and activation of bone resorbing activity of osteoclasts. In agreement with this, studies in animal models of RA have demonstrated the high therapeutic efficacy of specific inhibitors of NF-κB pathway, indicating the feasibility of anti-NF-κB therapy for human disease.

Documentos Relacionados

• Paclitaxel (Taxol)-induced NF-kappaB translocation in murine macrophages.
• Inhibition of NF-kappaB DNA binding by nitric oxide.
• Identification of a novel NF-kappaB p50-related protein in B lymphocytes.
• Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells.
• Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.